165 related articles for article (PubMed ID: 9823318)
1. Harvey ras results in a higher frequency of mammary carcinomas than Kirsten ras after direct retroviral transfer into the rat mammary gland.
Thompson TA; Kim K; Gould MN
Cancer Res; 1998 Nov; 58(22):5097-104. PubMed ID: 9823318
[TBL] [Abstract][Full Text] [Related]
2. Decreased susceptibility to NMU-induced mammary carcinogenesis in transgenic rats carrying multiple copies of a rat ras gene driven by the rat Harvey ras promoter.
Thompson TA; Haag JD; Lindstrom MJ; Griep AE; Lohse JK; Gould MN
Oncogene; 2002 Apr; 21(18):2797-804. PubMed ID: 11973638
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma induction following direct in situ transfer of v-Ha-ras into rat mammary epithelial cells using replication-defective retrovirus vectors.
Wang BC; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1991 May; 51(10):2642-8. PubMed ID: 2021942
[TBL] [Abstract][Full Text] [Related]
4. Overcoming the activity of mammary carcinoma suppressor gene in Copenhagen rats by v-H-ras oncogene transfer into mammary epithelial cells in situ.
Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1991 Oct; 51(19):5298-303. PubMed ID: 1913652
[TBL] [Abstract][Full Text] [Related]
5. Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice.
Liu ML; Von Lintig FC; Liyanage M; Shibata MA; Jorcyk CL; Ried T; Boss GR; Green JE
Oncogene; 1998 Nov; 17(18):2403-11. PubMed ID: 9811472
[TBL] [Abstract][Full Text] [Related]
6. Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.
Gould MN; Moore CJ; Zhang R; Wang B; Kennan WS; Haag JD
Cancer Res; 1994 Jul; 54(13):3540-3. PubMed ID: 8012978
[TBL] [Abstract][Full Text] [Related]
7. Regions of H- and K-ras that provide organ specificity/potency in mammary cancer induction.
Kim K; Lindstrom MJ; Gould MN
Cancer Res; 2002 Mar; 62(5):1241-5. PubMed ID: 11888883
[TBL] [Abstract][Full Text] [Related]
8. Difference in the response of neu and ras oncogene-induced rat mammary carcinomas to early and late ovariectomy.
Wang B; Kennan WS; Yasukawa-Barnes J; Lindstrom MJ; Gould MN
Cancer Res; 1992 Aug; 52(15):4102-5. PubMed ID: 1353410
[TBL] [Abstract][Full Text] [Related]
9. Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Yu M; Shan L; Snyderwine EG
Oncogene; 2003 Feb; 22(8):1253-60. PubMed ID: 12606953
[TBL] [Abstract][Full Text] [Related]
10. Frequent activation of CArG binding factor-A expression and binding in N-methyl-N-nitrosourea-induced rat mammary carcinomas.
Mikheev AM; Inoue A; Jing L; Mikheeva SA; Li V; Leanderson T; Zarbl H
Breast Cancer Res Treat; 2004 Nov; 88(1):95-102. PubMed ID: 15538050
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of overexpressed genes in the mammary gland of rat strains carrying the mammary carcinoma suppressor (Mcs) gene.
Hsu LC; Gould MN
Cancer Res; 1993 Dec; 53(23):5766-74. PubMed ID: 8242634
[TBL] [Abstract][Full Text] [Related]
12. ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.
Thompson TA; Haag JD; Gould MN
Carcinogenesis; 2000 Oct; 21(10):1917-22. PubMed ID: 11023551
[TBL] [Abstract][Full Text] [Related]
13. Defective retrovirus insertion activates c-Ha-ras protooncogene in an MNU-induced rat mammary carcinoma.
Bera TK; Tsukamoto T; Panda DK; Huang T; Guzman RC; Hwang SI; Nandi S
Biochem Biophys Res Commun; 1998 Jul; 248(3):835-40. PubMed ID: 9704014
[TBL] [Abstract][Full Text] [Related]
14. Mutational and nonmutational activation of p21ras in rat colonic azoxymethane-induced tumors: effects on mitogen-activated protein kinase, cyclooxygenase-2, and cyclin D1.
Bissonnette M; Khare S; von Lintig FC; Wali RK; Nguyen L; Zhang Y; Hart J; Skarosi S; Varki N; Boss GR; Brasitus TA
Cancer Res; 2000 Aug; 60(16):4602-9. PubMed ID: 10969813
[TBL] [Abstract][Full Text] [Related]
15. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
[TBL] [Abstract][Full Text] [Related]
16. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
[TBL] [Abstract][Full Text] [Related]
17. Expression of activated M-Ras in a murine mammary epithelial cell line induces epithelial-mesenchymal transition and tumorigenesis.
Ward KR; Zhang KX; Somasiri AM; Roskelley CD; Schrader JW
Oncogene; 2004 Feb; 23(6):1187-96. PubMed ID: 14961075
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53.
Cui XS; Donehower LA
Oncogene; 2000 Dec; 19(52):5988-96. PubMed ID: 11146550
[TBL] [Abstract][Full Text] [Related]
19. Affinity with Raf is sufficient for Ras to efficiently induce rat mammary carcinomas.
McFarlin DR; Lindstrom MJ; Gould MN
Carcinogenesis; 2003 Jan; 24(1):99-105. PubMed ID: 12538354
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a novel oncogenic K-ras mutation in colon cancer.
Akagi K; Uchibori R; Yamaguchi K; Kurosawa K; Tanaka Y; Kozu T
Biochem Biophys Res Commun; 2007 Jan; 352(3):728-32. PubMed ID: 17150185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]